General Meeting of the Global Alliance against Chronic Respiratory Diseases (GARD) and GARD Launch
|
|
- Colin Simmons
- 5 years ago
- Views:
Transcription
1 General Meeting of the Global Alliance against Chronic Respiratory Diseases (GARD) and GARD Launch March 2006 Beijing, People s Republic of China Wednesday, 29 March 2006 Session 2: Working Groups. Chairmanship, composition, 2005 annual report, 2006 action plan and indicators
2 The Lancet 2005;366:1514
3 Horton, The Lancet 2005
4 Horton, The Lancet 2005
5 Horton, The Lancet 2005
6
7 Strong et al, Lancet 2005
8 Strong et al, Lancet 2005
9 Strong et al, Lancet 2005
10 Strong et al, Lancet 2005
11
12 Epping-Jordan et al, Lancet 2005
13
14 Reddy et al, Lancet 2005
15
16 Fan Wu et al, Lancet 2005
17
18
19 Presidents of respiratory societies participating in FIRS
20
21
22
23 Chapman et al, ERJ 2006
24 Chapman et al, ERJ 2006
25 Chapman et al, ERJ 2006
26 Chapman et al, ERJ 2006
27 Chapman et al, ERJ 2006
28
29 Lopez et al, ERJ 2006
30 Lopez et al, ERJ 2006
31 Lopez et al, ERJ 2006
32 Lopez et al, ERJ 2006
33 Lopez et al, ERJ 2006
34 Lopez et al, ERJ 2006
35
36 Mannino et al, ERJ 2006
37 Mannino et al, ERJ 2006
38
39 Menezes, Lancet 2005
40 Respir Med Feb;97(2): Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K; Obstructive Lung Disease in Northern Sweden Studies. In 1996, 5892 of the Obstructive Lung Disease in Northern Sweden (OLIN) Study's first cohort could be traced to a third follow-up survey, and 5189 completed responses (88%) were received corresponding to 79% of the original cohort from December Of the responders, a random sample of 1500 subjects were invited to a structured interview and a lung function test, and 1237 of the invited completed a lung function test with acceptable quality. In ages >45 years, the prevalence of COPD according to the BTS guidelines was 8%, while it was 14% according to the GOLD criteria and approximately a half of elderly smokers fulfilled the criteria for COPD according to both the BTS and the GOLD criteria. Of those fulfilling the BTS criteria for COPD, 94% were symptomatics, 69% had chronic productive cough, but only 31% had prior to the study been diagnosed as having either chronic bronchitis, emphysema, or COPD. The corresponding figures for COPD according GOLD were 88, 51, and 18%.
41 CHEST 2005
42 Lindberg et al, CHEST 2005
43 2005
44 Johannessen, IJTLD 2005
45 WG-1: Epidemiology and Surveillance (G Viegi): Chair: G. Viegi, Italy (ERS); Co-Chairs: S. Buist, USA (GOLD), Y. Fukuchi (APSR). WHO-Liaison Officers: E. Mantsouranis. Proposed initial composition: I. Annesi (ERS), R. Beasley (?), P. Burney (GA2LEN), W. Canonica (WAO), B. Chipps (ACAAI), E. Duran (ERS), J. Jardim (ALAT), D.S. Kim (APSR), A. Kocabas (TTS), C. Lai (AAAF), Lee Todd (BOLD), B. Lundback (ERS), J. Mallol (?), D. Mannino (ATS?), D. Nugmanova (WONCA), J.A. Odhiambo (IUATLD?), R Pawankar (ARIA?), J Vestbo (ERS).
46 2005 Annual report The WG chairpersons have participated in the preparatory meetings held in Geneva and Copenhagen and have indicated the major needs in terms of epidemiology and surveillance of CRD and allergies. They have discussed the Terms of References of GARD. They have also identified the human resources needed to carry out the action plan, once the GARD budget has been established.
47 General Objective The goal of this WG is to develop a standardized process to obtain data risk factors, disease burden, trends, quality and affordability of care and the economic burden of chronic respiratory diseases (CRD) and allergies that can then be compared across countries.
48 Aims: 1. Use WHO programmes and non-who programmes to make an inventory of existing studies/reports that have collected data on prevalence, risk factors, severity, and economic burden of chronic respiratory diseases. 2. Collect these data at a country-based level. 3. Expand WHO internal initiatives (routine statistics, information systems, projection models) to cover respiratory and allergic diseases.
49 Plan of work (I): 1. Develop the methodology and selection of key words. 2. Review the literature published in the last 10 years. 3. Calculate the PAR (Population Attributable Risk) for host and environmental factors. 4. Include these data in the Info base of WHO.
50 Plan of work (II): 5. Develop and test methods for estimating the economic burden of chronic respiratory diseases. 6. Validate the existing models aimed at forecasting disease prevalence and economic burden. 7. Identify standardized methods for prevalence surveys for the CRD of interest and establish standards for carrying out these surveys. 8. Develop risk charts for educational purposes.
51 Action Plan Year 1 (I) Once the WG is fully established and the necessary work force recruited, the first activity will be a full description of the epidemiology of COPD. This is motivated by the COPD epidemic that is largely unrecognized at governmental level and challenged by the misuse of common indicators such as death certificates. The first work to be carried out will be: 1. Definition of the methodology and selection of key words.
52 Action Plan Year 1 (II) 2. Review of the literature published in the last 10 years. An important basis for enlisting existing data on COPD prevalence will be the article of Halbert RJ et al (Chest 2003), and an updated systematic review and meta analysis, also by Halbert et al (in Press in ERJ) A review and updating of this paper, if necessary, will be the first task of WG 1.
53 Action Plan Year 1 (III) 3. Review of existing and ongoing initiatives and projects, e.g.: BOLD, ERS White Book, GINA Global Burden of Asthma, Healthy people 2010 goals for respiratory diseases (NHLBI), IMCA (Indicators for monitoring COPD and asthma in the EU), ISAAC, PLATINO, 2003 NHLBI Fact Book, 2003 NHLBI Chart Book, South African Thoracic Society plan to develop an African White Book.
54 Action Plan Year 1 (IV) 4. Dissemination of the outcome of the Task Force on Simple Spirometry, carried out by the Forum of International Respiratory Societies (FIRS) (due to finish in the fall of 2006).
55 Deliverables: 1.1. An inventory of recent studies (published in the last ten years) with COPD prevalence data Definition of standardized methods needed to carry out comparable epidemiological surveys on CRD and allergic diseases of interest.
56 References: 1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause : Global Burden of Disease Study. Lancet 1997 May 24;349(9064): Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in Lancet 2003 Sep 13; 362 (9387) : Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006 Feb;27(2): He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK. Major causes of death among men and women in China. N Engl J Med 2005 Sep 15;353(11):
57 References: 5. Wagner PD, Viegi G, Luna CM, Fukuchi Y, Kvale PA, El Sony A. Major causes of death in China. N Engl J Med 2006 Feb 23;354(8):874-6; author reply Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003 May;123(5): Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003 Nov;22(5): Viegi G, Matteelli G, Angino A, Scognamiglio A, Baldacci S, Soriano JB, Carrozzi L. The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest 2004 Oct;126(4): Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003 Aug;22(2):
58 References: 10. Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, Davey Smith G, Upton M, Hawthorne V, Sin DD, Man SF, Van Eeden S, Mapel DW, Vestbo J. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006 Mar;27(3): Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, Takahashi K, Nishimura K, Ishioka S, Aizawa H, Zaher C. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004 Nov;9(4): Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG; PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005 Nov 26;366(9500): Halber RJ, Natoli JL, Gano A, Badamgarav E, Buist AS and Mannino DM. Global Burden of COPD : Systematic review and meta-analysis Eur Resp J 2006, in Press
59 CHEST 2003; 123:
60 1-2 digits TO BE CONTINUED 1/3 CHEST 2003; 123:
61 1-2 digits TO BE CONTINUED 2/3 CHEST 2003; 123:
62 1-2 digits <1 digit CHEST 2003; 123:
63 CHEST 2003; 123:
64 Eur Respir J 2003;22:
65 FEV1/FVC <70% (GOLD) Lower limit of normal $ Self-report NHANES III Study Celli et al, ERJ 2003 $ = ERS/ATS 2005
66 2 edition: in preparation
67 Needed human resources 1. Job description: Consultants in epidemiology: selection of usable prevalence studies and countries for new surveys. Consultants in biostatistics: PAR and risk charts calculations and models verification. Consultants in health economics: burden calculations. Consultant in information system: liaison with in-house WHO initiatives. 2. Work-force needed (to be budgeted): One full-time PhD in Epidemiology. One half-time PhD in Biostatistics. One part-time PhD in Economics. One part-time expert in Information system.
Epidemiology of COPD Prof. David M. Mannino, M.D.
Epidemiology of COPD David M. Mannino, M.D. Professor Department of Preventive Medicine and Environmental Health College of Public Health University of Kentucky 1 Outline Definitions Severity Progression
More informationThe global burden of chronic respiratory diseases
Key points Currently, the serious consequences of chronic diseases and their risk factors are not fully recognised by the international health community. In the period of 1990 2020, COPD deaths are expected
More informationEpidemiology, pathophysiology, diagnosis of COPD and the implementation of GOLD guidelines a short review
REVIEW ARTICLE DOI: http://dx.doi.org/10.29387/ms.2014.2.3.135-140 Epidemiology, pathophysiology, diagnosis of COPD and the implementation of GOLD guidelines a short review Dandagi G Correspondence to:
More information) * + % ) & ! "#$$% & '(("
) * + % ) &,-! "#$$% & '((" %. / ) * + % 0* + % 12 2 3 0'(("1 / * + % &,,,- / ) &,- 0 12.. -, / &, - / 2 3 ) &, 3! 4(((((( 5% 5657% +% 6685858 6'((4 .. Cardiovascular diseases mainly heart disease and
More informationKey words: COPD; diagnosis; epidemiology; gender; incidence; prevalence; respiratory symptoms; risk factors
Ten-Year Cumulative Incidence of COPD and Risk Factors for Incident Disease in a Symptomatic Cohort* Anne Lindberg, MD; Ann-Christin Jonsson, SRN; Eva Rönmark, PhD; Rune Lundgren, MD, PhD, FCCP; Lars-Gunnar
More informationPrevalence of Chronic Obstructive Pulmonary Disease in China A Large, Population-based Survey
Prevalence of Chronic Obstructive Pulmonary Disease in China A Large, Population-based Survey Nanshan Zhong 1, Chen Wang 2, Wanzhen Yao 3, Ping Chen 4, Jian Kang 5, Shaoguang Huang 6, Baoyuan Chen 7, Changzheng
More informationThis is a cross-sectional analysis of the National Health and Nutrition Examination
SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is
More informationPrevalence of Chronic Obstructive Pulmonary Disease and Tobacco Use in Veterans at Boise Veterans Affairs Medical Center
Prevalence of Chronic Obstructive Pulmonary Disease and Tobacco Use in Veterans at Boise Veterans Affairs Medical Center William H Thompson MD and Sophie St-Hilaire DVM PhD BACKGROUND: Although its prevalence
More informationPrevalence of Chronic Obstructive Pulmonary Disease in Japanese People on Medical Check-Up
Tohoku J. Exp. Med., 2005, 207, Prevalence 41-50 of COPD on Medical Check-Up 41 Prevalence of Chronic Obstructive Pulmonary Disease in Japanese People on Medical Check-Up HIDEKAZU TAKEMURA, WATARU HIDA,
More informationChronic respiratory diseases at primary health care level in Georgia: the results of the pilot study
Monaldi Arch Chest Dis 2009; 71: 4, 141-146 ORIGINAL ARTICLE Chronic respiratory diseases at primary health care level in Georgia: the results of the pilot study I. Chkhaidze 1, T. Maglakelidze 2, N. Khaltaev
More informationOnline Data Supplement. Prevalence of Chronic Obstructive Pulmonary Disease in Korea: Results of a Population-based Spirometry Survey
Online Data Supplement Prevalence of Chronic Obstructive Pulmonary Disease in Korea: Results of a Population-based Spirometry Survey Dong Soon Kim, MD, Young Sam Kim MD, Kee Suk Chung MD, Jung Hyun Chang
More informationSUMMARY OF THE RMP. Boehringer Ingelheim International GmbH, Ingelheim, Germany 2.2 ELEMENTS FOR SUMMARY TABLES IN THE EPAR
PART VI SUMMARY OF THE RMP Active substance Product concerned Name of Marketing Authorisation Holder or Applicant Olodaterol Striverdi Respimat Data lock point for this module 31 Jan 2014 Version number
More informationChronic bronchitis has been defined as. The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study
Eur Respir J 2012; 40: 28 36 DOI: 10.1183/09031936.00141611 CopyrightßERS 2012 The chronic phenotype in subjects with and without COPD: the PLATINO study Maria Montes de Oca*, Ronald J. Halbert #, Maria
More informationPhysician-Diagnosed COPD Global Initiative for Chronic Obstructive Lung Disease Stage IV in Östersund, Sweden*
Original Research COPD Physician-Diagnosed COPD Global Initiative for Chronic Obstructive Lung Disease Stage IV in Östersund, Sweden* Patient Characteristics and Estimated Prevalence Nikolai Stenfors,
More informationCOPD in Korea. Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum
COPD in Korea Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum Mortality Rate 1970-2002, USA JAMA,2005 Global Burden of Disease: COPD WHO & World
More informationT he recent international guidelines from the Global
842 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study A Johannessen, E R Omenaas, P
More informationHigh Prevalence of Chronic Obstructive Pulmonary Disease Among Veterans in the Urban Midwest
MILITARY MEDICINE, 176, 5:552, 2011 High Prevalence of Chronic Obstructive Pulmonary Disease Among Veterans in the Urban Midwest Daniel E. Murphy, MD * ; Zeshan Chaudhry * ; Khalid F. Almoosa, MD, MS ;
More informationWhy does WHO worry? The global epidemic of chronic respiratory diseases
Why does WHO worry? The global epidemic of chronic respiratory diseases Alvaro A. Cruz, M.D. Chronic Respiratory Diseases Group WHO/GARD Nordic Seminar, 15 November 2007, Oslo The epidemic of chronic respiratory
More informationCOPD Prevalence in Salzburg, Austria* Results From the Burden of Obstructive Lung Disease (BOLD) Study
Original Research COPD COPD Prevalence in Salzburg, Austria* Results From the Burden of Obstructive Lung Disease (BOLD) Study Lea Schirnhofer, MD; Bernd Lamprecht, MD; William M. Vollmer, PhD; Michael
More informationVoluntary pulmonary function screening identifies high rates of undiagnosed asymptomatic chronic obstructive pulmonary disease
Original Article Voluntary pulmonary function screening identifies high rates of undiagnosed asymptomatic chronic obstructive pulmonary disease Chronic Respiratory Disease 2016, Vol. 13(2) 137 143 ª The
More informationCitation for the original published paper (version of record):
http://www.diva-portal.org This is the published version of a paper published in The International Journal of Chronic Obstructive Pulmonary Disease. Citation for the original published paper (version of
More informationLung function testing in the elderly Can we still use FEV 1 /FVCo70% as a criterion of COPD?
Respiratory Medicine (2007) 101, 1097 1105 Lung function testing in the elderly Can we still use FEV 1 /FVCo70% as a criterion of COPD? Astri Medbø, Hasse Melbye Institute of Community Medicine, University
More informationEpidemiology of chronic obstructive pulmonary disease: Health effects of air pollution
Blackwell Publishing AsiaMelbourne, AustraliaRESRespirology1323-77992006 Blackwell Publishing Asia Pty Ltd? 2006115523532Review ArticleEpidemiology of chronic obstructive pulmonary diseaseg Viegi et al.
More informationChronic obstructive pulmonary disease (COPD) is a major case of chronic morbidity
26 Journal of the association of physicians of india march 2014 VOL. 62 Original Article Early Detection of Chronic Obstructive Pulmonary Disease in Asymptomatic Smokers using Spirometry MS Barthwal *,
More informationReduced lung function in midlife and cognitive impairment in the elderly
Page 1 of 5 Reduced lung function in midlife and cognitive impairment in the elderly Giuseppe Verlato, M.D. Ph.D Department of Diagnostics and Public Health University of Verona Verona, Italy Mario Olivieri,
More informationEconomic Modeling in Chronic Obstructive Pulmonary Disease
Economic Modeling in Chronic Obstructive Pulmonary Disease Maureen Rutten-van Mölken and Todd A. Lee Erasmus Medical Center, Institute for Medical Technology Assessment, Rotterdam, The Netherlands; and
More informationC hronic obstructive pulmonary disease (COPD) is one of
935 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Developing COPD: a 25 year follow up study of the general population A Løkke, P Lange, H Scharling, P Fabricius, J Vestbo... See end of article for authors affiliations...
More informationPredictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Correspondence to: M Albers, Radboud University Nijmegen Medical Centre, Department of Primary Care [117-HAG], PO Box 9101, 6500 HB
More informationFactors affecting severity, functional parameters, and quality of life in COPD patients
REVIEW ARTICLE JIACM 2014; 15(1): 42-6 Factors affecting severity, functional parameters, and quality of life in COPD patients M Uppal*, B Gupta**, JC Suri***, V Mittal**** Abstract Background: Chronic
More informationPrevalence of undetected persistent airflow obstruction in male smokers years old
2 Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old Geijer RMM Sachs APE Hoes AW Salomé PL Lammers J-WJ Verheij TJM Published in: Family Practice 2005;22:485-489 Abstract
More information2010 YEAR OF THE LUNG: GOALS AND OBJECTIVES. J. Randall Curtis, MD, MPH Immediate Past President, ATS
2010 YEAR OF THE LUNG: GOALS AND OBJECTIVES J. Randall Curtis, MD, MPH Immediate Past President, ATS 2010 Year of the Lung What is Year of the Lung? Whey do we need a Year of the Lung? What does Year of
More informationBRONHODILATOR RESPONSE TO NEBULIZED SALBUTAMOL IN ELDERLY PATIENTS WITH STABLE C.O.P.D
ORIGINAL AR TICLE BRONHODILATOR RESPONSE TO NEBULIZED SALBUTAMOL IN ELDERLY PATIENTS WITH STABLE C.O.P.D Mohammad Hussain Khan, Arshad Javaid Department of Pulmonology, Post graduate Medical Institute
More informationERJ Express. Published on January 26, 2012 as doi: /
ERJ Express. Published on January 26, 2012 as doi: 10.1183/09031936.00141611 Chronic Bronchitis Phenotype in subjects with and without COPD: the PLATINO study Maria Montes de Oca Servicio de Neumonología,
More informationIntroduction. Original Article
Original Article Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study Chronic Respiratory
More informationBoth environmental tobacco smoke and personal smoking is related to asthma and wheeze in teenagers
< An additional table is published online only. To view this file, please visit the journal online (http://thorax.bmj.com). 1 The OLIN-studies, Sunderby Central Hospital of Norrbotten, Luleå, Sweden 2
More informationChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study Ana Maria B Menezes, Rogelio Perez-Padilla, José Roberto B Jardim, Adriana Muiño, Maria Victorina
More informationAround-COPD Verona (Italy), January Highlights
Introduction Around-COPD Verona (Italy), January 18 2017 Highlights Prof. Dal Negro chairman of the symposium, opened the congress by highlighting the burden of COPD as a chronic invalidating disease affecting
More informationThis article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and
This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution
More informationThe role of blood eosinophil level in acute exacerbation of Chronic Obstructive Pulmonary Disease
112 Original Article The role of blood eosinophil level in acute exacerbation of Chronic Obstructive Pulmonary Disease Department of Pulmonology and Critical Care Medicine, Tribhuvan University Teaching
More informationCOPO Prevalence in Southeastem Kentucky* The Burden of Lung Disease Study
Original Research COPD COPO Prevalence in Southeastem Kentucky* The Burden of Lung Disease Study Jennifer N. Methvin, MPH; David M. Mannino, MD, FCCP; and Baretta R. Casey, MD Background: The Burden ofobstructive
More informationClinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study
ORIGINAL ARTICLE COPD Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study Masaru Suzuki 1, Hironi Makita 1, Yoichi M. Ito 2, Katsura Nagai 1, Satoshi Konno 1 and Masaharu
More informationCOPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases
COPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases «If you test one smoker with cough every day You will diagnose
More informationHealth-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index
Chronic Respiratory Disease 2009; 6: 75 80 http://crd.sagepub.com ORIGINAL PAPER Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index
More informationLife-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton
Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary
More informationTHE PLATINO COHORT STUDY: THE NATURAL HISTORY OF COPD
FEDERAL UNIVERSITY OF PELOTAS POST-GRADUATE PROGRAM IN EPIDEMIOLOGY THE PLATINO COHORT STUDY: THE NATURAL HISTORY OF COPD REPORT This report was prepared by ANA MARIA BAPTISTA MENEZES PEDRO CURI HALLAL
More informationHealth-related quality of life in chronic obstructive pulmonary disease patients in Korea
Kim et al. Health and Quality of Life Outcomes 2014, 12:57 RESEARCH Open Access Health-related quality of life in chronic obstructive pulmonary disease patients in Korea Seon-Ha Kim 1, Yeon Mok Oh 2 and
More informationBody mass index and chronic obstructive pulmonary disease-related mortality: a nationally representative prospective study of men in China
Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 2010; all rights reserved. Advance Access publication 16 April 2010 International Journal of
More informationPrevalence of COPD in Copenhagen
Respiratory Medicine (2011) 105, 410e417 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Prevalence of COPD in Copenhagen Peder Fabricius a, *, Anders Løkke b, Jacob Louis
More informationPrevalence, severity and underdiagnosis of COPD in the primary care setting
See Editorial, p 387 c Supplementary table 1 and figs 1 and 2 are published online only at http://thorax.bmj.com/ content/vol63/issue5 1 2nd Department of Respiratory Medicine, National Research Institute
More informationThe effects of secondhand smoke on chronic obstructive pulmonary disease in nonsmoking Korean adults
ORIGINAL ARTICLE Korean J Intern Med 2014;29:613-619 The effects of secondhand smoke on chronic obstructive pulmonary disease in nonsmoking Korean adults Woong Jun Kim 1, June Seok Song 2, Dong Won Park
More informationAsthma Tutorial. Trainer MRW. Consider the two scenarios, make an attempt at the questions, what guidance have you used?
Registrar: LG PR RS Topic Asthma and COPD Asthma Tutorial Trainer MRW Date of Tutorial 18 th Jan 2007 Objectives of the tutorial How to diagnose What investigations and when Treatment guidelines QoF Criteria
More informationEffect Of Byrates (Barium Sulphate) On Pulmonary Function In Byrates Mine Workers
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 01 Ver. I January. (2018), PP 46-50 www.iosrjournals.org Effect Of Byrates (Barium Sulphate)
More informationReliability of FEV 1 /FEV 6 to Diagnose Airflow Obstruction Compared with FEV 1 /FVC: The PLATINO Longitudinal Study
Reliability of FEV 1 /FEV 6 to Diagnose Airflow Obstruction Compared with FEV 1 /FVC: The PLATINO Longitudinal Study Rogelio Perez-Padilla 1 *, Fernando C. Wehrmeister 2, Bartolome R. Celli 3, Maria Victorina
More informationGARD collaborating parties
GARD collaborating parties Elisabetta Minelli, Technical Officer GARD General Meeting 1-2 June 2007 Seoul, Republic of Korea Overview The power of GARD collaborating parties Evolution of number of participants
More informationjournal Helena Backman 1,2*, Linnea Hedman 1, Sven-Arne Jansson 1,2, Anne Lindberg 1,3, Bo Lundbäck 1,4 and Eva Rönmark 1,2
Backman et al. World Allergy Organization Journal 2014, 7:1 journal ORIGINAL RESEARCH Open Access Prevalence trends in respiratory symptoms and asthma in relation to smoking - two cross-sectional studies
More informationThe Relationship among COPD Severity, Inhaled Corticosteroid Use, and the Risk of Pneumonia.
The Relationship among COPD Severity, Inhaled Corticosteroid Use, and the Risk of Pneumonia. Rennard, Stephen I; Sin, Donald D; Tashkin, Donald P; Calverley, Peter M; Radner, Finn Published in: Annals
More informationAccording to the global burden of disease. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America
Eur Respir J 2007; 30: 1180 1185 DOI: 10.1183/09031936.00083507 CopyrightßERS Journals Ltd 2007 Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America A.M.B. Menezes*, P.C.
More informationIndian Journal of Basic and Applied Medical Research; December 2015: Vol.-5, Issue- 1, P
Original article Can Body Mass Index correlate with severity of Chronic Obstructive Pulmonary Disease? A cross sectional study done in rural population of Jaipur Asif Feroz, Sachet Dawar, Shivani Swami,
More informationPredictors of cardiovascular disease in asthma and chronic obstructive pulmonary disease
Bellocchia et al. Multidisciplinary Respiratory Medicine 2013, 8:58 ORIGINAL RESEARCH ARTICLE Open Access Predictors of cardiovascular disease in asthma and chronic obstructive pulmonary disease Michela
More informationComparison between Spirometry and BODE Index for Clinical Assessment in Chronic Obstructive Pulmonary Disease Patients
Trends in Medical Research 10 (1): 12-18, 2015 ISSN 1819-3587 / DOI: 10.3923/tmr.2015.12.18 2015 Academic Journals Inc. Comparison between Spirometry and BODE Index for Clinical Assessment in Chronic Obstructive
More informationAmerican Thoracic Society (ATS) Perspective
National Surveillance System for Chronic Lung Disease (CLD): American Thoracic Society (ATS) Perspective Gerard J. Criner, M.D. Chronic Obstructive Pulmonary Disease (COPD) l Definition: Group of chronic
More informationCT Assessment of Lobar Heterogenity and Fissure Integrity in Pulmonary Emphysema for Bronchoscopic Lung Volume Reduction with Valve
CT image analysis of emphysema. 77 Original Article J. St. Marianna Univ. Vol. 5, pp. 77 83, 2014 CT Assessment of Lobar Heterogenity and Fissure Integrity in Pulmonary Emphysema for Bronchoscopic Lung
More informationACTIONS AGAINST CHRONIC RESPIRATORY DISEASES (CRDs( ITALY
ACTIONS AGAINST CHRONIC RESPIRATORY DISEASES (CRDs( CRDs) ) IN ITALY STEFANO NARDINI Department Pulmonary Disease Vittorio Veneto Hospital (TV), ITALY Secretary General, AIMAR On behalf of the Centre for
More informationPeriodontitis modifies the association between smoking and chronic obstructive pulmonary disease in Japanese men
226 Journal of Oral Science, Vol. 60, No. 2, 226-231, 2018 Original Periodontitis modifies the association between smoking and chronic obstructive pulmonary disease in Japanese men Jane Harland 1), Michiko
More informationQUALITY OF LIFE MEASURED BY THE ST GEORGE'S RESPIRATORY QUESTIONNAIRE AND SPIROMETRY
ERJ Express. Published on January 22, 2009 as doi: 10.1183/09031936.00116808 QUALITY OF LIFE MEASURED BY THE ST GEORGE'S RESPIRATORY QUESTIONNAIRE AND SPIROMETRY 1 Mark Weatherall, 2 Suzanne Marsh, 2 Philippa
More informationPredictors of obstructive lung disease among seafood processing workers along the West Coast of the Western Cape Province
Predictors of obstructive lung disease among seafood processing workers along the West Coast of the Western Cape Province Adams S 1, Jeebhay MF 1, Lopata AL 2, Bateman ED 3, Smuts M 4, Baatjies R 1, Robins
More informationTHE PHARMA INNOVATION - JOURNAL Clinical Characteristics of Chronic Obstructive Pulmonary Disease
Received: 09012014 Accepted: 30032014 ISSN: 2277 7695 CODEN Code: PIHNBQ ZDBNumber: 26630382 IC Journal No: 7725 Vol. 3 No. 2. 2014 Online Available at www.thepharmajournal.com THE PHARMA INNOVATION JOURNAL
More informationAlthough chronic obstructive pulmonary. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study
Eur Respir J 2009; 34: 588 597 DOI: 10.1183/09031936.00164608 CopyrightßERS Journals Ltd 2009 Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study W.M. Vollmer*, þ.
More informationPerché le malattie respiratorie sono sottodiagnosticate. S. Harari
Perché le malattie respiratorie sono sottodiagnosticate S. Harari DALYs: disability adjusted life years BPCO causa importante e crescente di morbilità e di mortalità in tutto il mondo nel 2004 4 causa
More informationRESEARCH PROTOCOL PROPOSAL
RESEARCH PROTOCOL PROPOSAL UNCOVERING AND NOTING LONG-TERM OUTCOMES IN COPD AND ASTHMA TO ENHANCE KNOWLEDGE - UNLOCK UNLOCK Study: The prevalence of comorbidities in COPD patients and their impact on the
More informationCigarette Smoking and Lung Obstruction Among Adults Aged 40 79: United States,
NCHS Data Brief No. 8 January 25 Cigarette Smoking and Lung Obstruction Among Adults Aged 4 79: United States, 27 22 Ryne Paulose-Ram, Ph.D., M.A.; Timothy Tilert, B.S.; Charles F. Dillon, M.D., Ph.D.;
More informationPopulation-Based Study on the Prevalence of Spirometric Obstructive Pattern in Porto, Portugal
Population-Based Study on the Prevalence of Spirometric Obstructive Pattern in Porto, Portugal Joana Mascarenhas MD, Helena Falcão MD, Patrícia Lourenço MD, Cristiana Paulo MD, Marta Patacho MD, Paulo
More informationSurvey on Chronic Respiratory Diseases at the PrimaryHealth Care Level
Survey on Chronic Respiratory Diseases at the PrimaryHealth Care Level Nikolai Khaltaev MD, PhD GARD General Meeting Istanbul, Turkey, 30-31 May 2008 Burden of major respiratory diseases Respiratory diseases
More informationDr Conroy Wong. Professor Richard Beasley. Dr Sarah Mooney. Professor Innes Asher
Professor Richard Beasley University of Otago Director Medical Research Institute of New Zealand Wellington Dr Sarah Mooney Physiotherapy Advanced Clinician Counties Manukau Health NZ Respiratory and Sleep
More information9/22/2015 CONFLICT OF INTEREST OBJECTIVES. Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationUnderstanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationImpact of Bronchodilator Use on the Prevalence of COPD in Population-Based Samples
COPD: Journal of Chronic Obstructive Pulmonary Disease, 4:113 120 ISSN: 1541-2555 print / 1541-2563 online Copyright c 2007 Informa Healthcare DOI: 10.1080/15412550701341012 ORIGINAL RESEARCH Impact of
More informationFEV 1 /FVC and FEV 1 for the assessment of chronic airflow obstruction in prevalence studies: Do prediction equations need revision?
Respiratory Medicine (2008) 102, 1568e1574 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed FEV 1 /FVC and FEV 1 for the assessment of chronic airflow obstruction in prevalence
More informationThe beneficial effects of ICS in COPD
BIOLOGY AND HEALTH Journal website: www.biologyandhealth.com Narrative review The beneficial effects of ICS in COPD Stacha Reumers Stacha Reumers I6111431 Maastricht University Faculty of Health, Medicine
More informationFeasibility and validation of telespirometry in general practice: The Italian Alliance study *
Respiratory Medicine (2009) 103, 1732e1737 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Feasibility and validation of telespirometry in general practice: The Italian
More informationOutline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?
Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado
More informationPrevalence of asthma COPD overlap syndrome among primary care asthmatics with a smoking history: a cross-sectional study
www.nature.com/npjpcrm All rights reserved 2055-1010/15 ARTICLE OPEN among primary care asthmatics with a smoking history: a cross-sectional study Toni Kiljander 1, Timo Helin 2, Kari Venho 3, Antero Jaakkola
More informationAutologous Stem Cell Therapy & its Effects on COPD:
Autologous Stem Cell Therapy & its Effects on COPD: A Pilot Study Jack Coleman Jr., M.D. LungInstitute.com (855) 469-5864 Introduction by the Lung Institute The Problem with Chronic Pulmonary Diseases
More informationKey words: asthma; COPD; epidemiology; obstructive lung disease; Venn diagram
The Proportional Venn Diagram of Obstructive Lung Disease* Two Approximations From the United States and the United Kingdom Joan B. Soriano, MD; Kourtney J. Davis, PhD; Bobbie Coleman, BSc; George Visick,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Moran A, Zhao D, Gu D, et al. The Future Impact of Population
More informationCitation for the original published paper (version of record): N.B. When citing this work, cite the original published paper.
http://www.diva-portal.org This is the published version of a paper published in European Clinical Respiratory Journal. Citation for the original published paper (version of record): Lindberg, A., Linder,
More informationIndicator of arteriosclerosis in patients with COPD
ORIGINAL ARTICLES Indicator of arteriosclerosis in patients with COPD Akinori Ebihara 1 Akifumi Watanabe 2 Asuka Nagai 1 Rurika Hamanaka 3 Naoko Imamura 3 Chizumi Yamada 4 Tokuzen Iwamoto 1 Ichiro Kuwahira
More informationChronic obstructive pulmonary disease. COPD prevalence and its association with occupational exposures in a general population
Eur Respir J 2010; 36: 488 493 DOI: 10.1183/09031936.00038309 CopyrightßERS 2010 COPD prevalence and its association with occupational exposures in a general population A.M. Melville*,#, T. Pless-Mulloli
More informationClinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene
Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Emily S. Wan, John E. Hokanson, James R. Murphy, Elizabeth A. Regan, Barry J. Make, David A. Lynch, James D. Crapo, Edwin K.
More informationBreaking Down Barriers to Pulmonary Therapies: Patient Education, Teach Back, and More
Breaking Down Barriers to Pulmonary Therapies: Patient Education, Teach Back, and More Char Raley, RRT Brandon Johnson, PharmD, BCPS Pulmonary and Critical Care Symposium June 12 th, 2015 We have had no
More informationAssociation between Airflow Obstruction and the Metabolic Syndrome or Its Components in Japanese Men
ORIGINAL ARTICLE Association between Airflow Obstruction and the Metabolic Syndrome or Its Components in Japanese Men Yayoi Funakoshi 1, Hisamitsu Omori 1, Shuichi Mihara 2, Tohru Marubayashi 2 and Takahiko
More informationPrevalence of COPD and tobacco smoking in Malopolska region results from the BOLD Study in Poland
Prevalence of COPD and tobacco smoking in Malopolska region results from the BOLD Study in Poland Częstość występowania POChP i rozpowszechnienie palenia tytoniu w Małopolsce wyniki badania BOLD w Polsce
More informationERJ Express. Published on November 14, 2008 as doi: /
ERJ Express. Published on November 14, 2008 as doi: 10.1183/09031936.00118808 Occupational Exposures and COPD: An Ecological Analysis of International Data Paul D. Blanc a Ana Maria B. Menezes b Estel
More informationAvailable online at Scholars Research Library
Available online at www.scholarsresearchlibrary.com Annals of Biological Research, 2010, 1 (4) : 248-253 (http://scholarsresearchlibrary.com/archive.html) ISSN 0976-1233 CODEN (USA): ABRNBW A study on
More informationSGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life
SUPPLEMENTARY MATERIAL e-table 1: Outcomes studied in present analysis. Outcome Abbreviation Definition Nature of data, direction indicating adverse effect (continuous only) Clinical outcomes- subjective
More informationValorization. Valorization
Valorization Valorization 111 112 Valorization Valorization This chapter will discuss the current findings of this thesis in the light of the societal and economic impact as well as innovative concepts
More informationClinical significance in COPD patients followed in a real practice
de Oliveira et al. Multidisciplinary Respiratory Medicine 2013, 8:43 ORIGINAL ARTICLE Open Access Clinical significance in COPD patients followed in a real practice Júlio César Mendes de Oliveira 1,2,
More informationActivities and Plans of GARD Korea
Activities and Plans of GARD Korea You-Young Kim M.D., Ph.D. Korea Asthma Allergy Foundation (KAF) GARD General Meeting, May 30-31 2008, Istanbul, Turkey Overview Burden of major chronic respiratory diseases
More informationBurden of major Respiratory Diseases
Burden of major Respiratory Diseases WHO Survey Ryazan region of Russia, Ryazan region of Russia, health care system: 104 hospitals district hospitals 32 rural hospitals 44 65 out-patient departments
More informationSmoke, Biomass Exposure, and COPD Risk in the Primary Care Setting: The PUMA Study
Smoke, Biomass Exposure, and COD Risk in the rimary Care Setting: The UMA Study Maria Montes de Oca MD, Gustavo Zabert MD, Dolores Moreno MD, Maria E Laucho-Contreras MD, Maria Victorina Lopez Varela MD,
More information